tm logo

Monitor this mark

View On USPTO

IMITREX
Live/Registered
REGISTERED

on 17 Dec 2024

Last Applicant/ Owned by

Glaxo Group Limited

GSK Medicines Research Centre

Stevenage

GB

SG12NY

Serial Number

98398968 filed on 09th Feb 2024

Registration Number

7609019 registered on 17th Dec 2024

in the Principal Register

Correspondent Address

Christopher M. Hanes

Christopher M. Hanes GSK

Legal Brand Protection

Durham, NC 27701

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

IMITREX

Pharmaceutical preparations for the prevention, treatment and/or alleviation of migraine and other forms of headache

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the prevention, treatment and/or alleviation of migraine and other forms of headache

First Use Date in General

08th Aug 2003

First Use Date in Commerce

08th Aug 2003

Mark Details

Serial Number

No 98398968

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84273447

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.12 -

Chevrons and angles

Legal History

Status DateAction Taken
17th Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Dec 2024REGISTERED-PRINCIPAL REGISTER
15th Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Oct 2024PUBLISHED FOR OPPOSITION
25th Sep 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
30th Aug 2024ASSIGNED TO EXAMINER
08th Jun 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08th Jun 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
09th Feb 2024NEW APPLICATION ENTERED